Emerald Mutual Fund Advisers Trust Neuronetics, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Oct 31, 2018	SELL	$24.32 - $37.54 $1.43 Million - $2.21 Million	-59,000 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$26.61 - $27.78 $1.57 Million - $1.64 Million	59,000 New	59,000 $1.57 Million

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $48.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.